Irrational use of skin-bleaching products can delay the diagnosis of leprosy.
Mahé
Antoine
A
Ly
Fatimata
F
Badiane
Charles
C
Baldé
Yaya
Y
Dangou
Jean-Marie
JM
D000287:Administration, Topical; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D002610:Cheek / Q000473:pathology; D002990:Clobetasol / Q000009:adverse effects* / Q000031:analogs & derivatives*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D006873:Hydroquinones / Q000009:adverse effects*; D015439:Leprosy, Borderline / Q000175:diagnosis* / Q000473:pathology; D012867:Skin / Q000473:pathology; D013848:Thigh / Q000473:pathology
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D005938:Glucocorticoids; D006873:Hydroquinones; D002990:Clobetasol